Literature DB >> 4833964

Degree and duration of reversal by naloxone of effects of morphine in conscious subjects.

J M Evans, M I Hogg, J N Lunn, M Rosen.   

Abstract

The effects of intravenous naloxone on several of the actions of intravenous morphine (mean dose 30 mg/70 kg) were studied in six volunteer subjects. Naloxone produced a well defined reversal of the respiratory depression, analgesia, and miotic and subjective effects of the morphine. The agonist action of morphine outlasted the antagonist action of a single dose of naloxone. The effect of repeated doses of naloxone was also short-lived, but continuous infusions were effective in maintaining reversal.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4833964      PMCID: PMC1610781          DOI: 10.1136/bmj.2.5919.589

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  11 in total

1.  N-Allylnoroxy-morphone: a new potent narcotic antagonist.

Authors:  F F FOLDES; J N LUNN; J MOORE; I M BROWN
Journal:  Am J Med Sci       Date:  1963-01       Impact factor: 2.378

2.  Treatment of drug overdosage with naloxone, a specific narcotic antagonist.

Authors:  L E Evans; C P Swainson; P Roscoe; L F Prescott
Journal:  Lancet       Date:  1973-03-03       Impact factor: 79.321

3.  Antagonism of the subjective, behavioral, pupillary, and respiratory depressant effects of cyclazocine by naloxone.

Authors:  D R Jasinski; W R Martin; J D Sapira
Journal:  Clin Pharmacol Ther       Date:  1968 Mar-Apr       Impact factor: 6.875

4.  Treatment of propoxyphene overdosage with naloxone.

Authors:  E S Kersh
Journal:  Chest       Date:  1973-01       Impact factor: 9.410

5.  Metabolites of naloxone in human urine.

Authors:  S H Weinstein; M Pfeffer; J M Schor; L Indindoli; M Mintz
Journal:  J Pharm Sci       Date:  1971-10       Impact factor: 3.534

6.  The antagonism of morphine anesthesia by naloxone.

Authors:  J D Hasbrouck
Journal:  Anesth Analg       Date:  1971 Nov-Dec       Impact factor: 5.108

7.  Naloxone reversal of pentazocine-induced respiratory depression.

Authors:  T Kallos; T G Smith
Journal:  JAMA       Date:  1968-06-03       Impact factor: 56.272

8.  Naloxone in heroin dependence.

Authors:  M Fink; A Zaks; R Sharoff; A Mora; A Bruner; S Levit; A M Freedman
Journal:  Clin Pharmacol Ther       Date:  1968 Sep-Oct       Impact factor: 6.875

9.  The respiratory, circulatory, and narcotic antagonistic effects of nalorphine, levallorphan, and naloxone in anaesthetized subjects.

Authors:  F F Foldes; D Duncalf; S Kuwabara
Journal:  Can Anaesth Soc J       Date:  1969-03

10.  Isolation of two different glucuronide metabolites of naloxone from the urine of rabbit and chicken.

Authors:  J M Fujimoto
Journal:  J Pharmacol Exp Ther       Date:  1969-07       Impact factor: 4.030

View more
  19 in total

Review 1.  Naloxone in opioid poisoning: walking the tightrope.

Authors:  S F J Clarke; P I Dargan; A L Jones
Journal:  Emerg Med J       Date:  2005-09       Impact factor: 2.740

Review 2.  Naloxone dosage for opioid reversal: current evidence and clinical implications.

Authors:  Rachael Rzasa Lynn; J L Galinkin
Journal:  Ther Adv Drug Saf       Date:  2017-12-13

3.  Effects of naloxone on pethidine-induced neonatal depression. Part II--Intramuscular naloxone.

Authors:  P C Wiener; M I Hogg; M Rosen
Journal:  Br Med J       Date:  1977-07-23

4.  Effects of naloxone on pethidine-induced neonatal depression. Part I--Intravenous naloxone.

Authors:  P C Wiener; M I Hogg; M Rosen
Journal:  Br Med J       Date:  1977-07-23

5.  Use of narcotic antagonists in anaesthesia.

Authors:  J De Castro
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

6.  Naloxone Dosing After Opioid Overdose in the Era of Illicitly Manufactured Fentanyl.

Authors:  Joseph Carpenter; Brian Patrick Murray; Sukhshant Atti; Tim P Moran; Arthur Yancey; Brent Morgan
Journal:  J Med Toxicol       Date:  2019-08-30

7.  Dihydrocodeine overdose treated with naloxone infusion.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1983-11-19

8.  Maternal pethidine and neonatal depression.

Authors:  M Rosen; P C Wiener; M Hogg
Journal:  Br Med J       Date:  1978-02-18

9.  Lack of effect of naloxone in the irritable bowel syndrome.

Authors:  J F Fielding; K O'Malley
Journal:  Ir J Med Sci       Date:  1981-02       Impact factor: 1.568

Review 10.  An Introduction to the Endogenous Cannabinoid System.

Authors:  Hui-Chen Lu; Ken Mackie
Journal:  Biol Psychiatry       Date:  2015-10-30       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.